fosfluconazole has been researched along with epiglucan in 1 studies
| Studies (fosfluconazole) | Trials (fosfluconazole) | Recent Studies (post-2010) (fosfluconazole) | Studies (epiglucan) | Trials (epiglucan) | Recent Studies (post-2010) (epiglucan) |
|---|---|---|---|---|---|
| 23 | 6 | 6 | 5,066 | 241 | 3,169 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iishii, K; Inami, N; Kimura, E; Nomura, S; Urase, F | 1 |
1 other study(ies) available for fosfluconazole and epiglucan
| Article | Year |
|---|---|
Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Biomarkers; Candidiasis; Cell Adhesion Molecules; Chemokines; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Organophosphates; Platelet Activation; Prodrugs | 2007 |